ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Pretax margin (%)

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥545.1B
P/E ratio
15.1x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202614+6.54%
Mar 31, 202513.1-16.39%
Mar 31, 202415.7+5.13%
Mar 31, 202314.9+2.30%
Mar 31, 202214.6+10.45%
Mar 31, 202113.2+9.25%
Mar 31, 202012.1+16.83%
Mar 31, 201910.3-5.85%
Mar 31, 201811+6.29%
Mar 31, 201710.3+12.43%
Mar 31, 20169.2-1.13%
Mar 31, 20159.3-21.88%
Mar 31, 201411.9+4.24%
Mar 31, 201311.4+0.26%
Mar 31, 201211.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat